Cardiogeni signs MoU with Sheikh Al Qassimi for £20 million investment
LONDON: Cardiogeni (AQSE: CGNI), a UK-based clinical-stage biotechnology company founded by 2007 Nobel Laureate Sir Martin Evans, has announced the signing of a memorandum of understanding (MoU) with the Private Office of Sheikh Al Qassimi. This agreement is set to…